期刊文献+

来曲唑在临床中的应用研究 被引量:6

Exploratory Ddevelopment of Letrozole in Clinic
下载PDF
导出
摘要 来曲唑作为第3代芳香酶抑制剂,已被广泛应用于肿瘤领域。近些年,越来越多的研究表明,来曲唑在诸多妇产科临床疾病中具有应用前景。该药通过抑制芳香酶的活性,阻断雄烯二酮及睾酮向雌激素的转化,从而影响了雌激素的生物合成,降低体内雌激素水平。对盆腔子宫内膜异位症、子宫肌瘤、内膜癌、卵巢癌等妇产科疾病均有良好治疗效果,并能有效地促排卵而应用于辅助生育方面。 As the third generation of aromatase inhibitor,letrozole has been used widely in the sphere of tumor.In recent years,studies accumulated showed that letrozole had been used in several clinical diseases of gynecology and obstetrics with good perspective.It affects synthesis of E2 and then lower the E2 level in the body by inhibiting the activity of aromatase,obstructing the transformation of A and T to E2.It had good therapeutic effect on pelvic endometriosis,myoma of uterus,endometrial cancer,ovary cancer and so on.It can be applied in the field of assisted reproduction because of its effect on ovarian stimulation.
出处 《医学综述》 2008年第6期922-925,共4页 Medical Recapitulate
关键词 来曲唑 乳腺肿瘤 子宫内膜异位症 子宫肌瘤 促排卵 Letrozole Breast cancer Endometriosis Myoma of uterus Ovarian stimulation
  • 相关文献

参考文献21

  • 1Furbass R, Kalbe C, Vanselow J. Tissue-specific expression of the bovine aromatase-encoding gene uses multiple transcriptional start sites and alternative first exons [ J ]. Endocrinology, 1997,138 (7) : 2813-2819.
  • 2王燕,孙燕.乳腺癌内分泌治疗新药──来曲唑[J].中国新药杂志,1999,8(6):374-377. 被引量:17
  • 3Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years tamoxifen therapy for early-stage breast cancer[ J ]. N Engl J Med,2003,349 ( 19 ) : 1793- 1802.
  • 4Fang Z, Yang S, Gurates B, et al. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue [ J ]. Clin Endocrinol Metab ,2002,87 (7) : 3460-3466.
  • 5Shippen ER, West WJ. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor[J]. Fertil Steril,2004,81 ( 5 ) : 1395-1398.
  • 6Ailawadi RK, Jobanputra S, Kataria M, et al. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate : a pilot study [ J ]. Fertil Steril,200d ,81 (4) :290-296.
  • 7Fatemi HM, Al-Turki HA, Papanikolaou EG, et al. Successful treatment of an aggressive recurrent post-menopansal endometriosis with an aromatase inhibitor [ J ]. Reprod Biomed Online, 2005,11 (4) : 455- 457.
  • 8Shozu M, sumitani H, Segawa T, et al. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate [ J ]. Clin Endocrinol Metab ,2001,86 ( 11 ) :5405-5411.
  • 9Shozu M,Mumkami K,Segawa T,et al. Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor [ J ]. Fertil Steril, 2003,79 ( 3 ) : 1012-1017.
  • 10Pavnter RA, Hankinson SE, Colditz GA, et al. CYP19 (aromatase) haplotypes and endometrial cancer risk [ J ]. Int J Cancer, 2005, 116(2) :267-274.

共引文献16

同被引文献40

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部